Company Overview
- Headquarters
- 2450 Holcombe Blvd, Suite J, Houston TX
- Website
- asyliatx.com
- Employees
- 4
- Industry
- BioTech/Drugs
Financials & Stats
Revenue
$3B
Who is Asylia Therapeutics
Asylia Therapeutics is a private, development-stage biotechnology company based in Houston, Texas. Founded in August 2019, Asylia Therapeutics is a small company with four employees. Asylia Therapeutics is dedicated to developing novel immune modulating therapies for cancer and autoimmune diseases. Their drug pipeline focuses on modulating antigen presentation to the immune system, a strategy that has demonstrated promising anti-tumor results in various cancer models. The company's platform has shown remarkable potential in producing anti-tumor responses across a range of established cancer models. Asylia Therapeutics believes their approach has the potential to significantly impact the millions of Americans affected by cancer and autoimmune diseases. For more information about Asylia Therapeutics and their innovative therapies, visit their website at asyliatx.com.
Company Leadership
Companies Similar to Asylia Therapeutics
Analyze industry trends and opportunities by examining competitors and companies comparable to Asylia Therapeutics, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 3M | Arvada, CO | |||
| 3M | 6 | Star Valley Ranch, WY | ||
| 3M | 4 | Ann Arbor, MI | 2006 | |
| 3M | 3 | San Diego, CA | ||
| 3M | 3 | New York, NY |